- Type / Class
- Equity / Common Stock
- Shares outstanding
- 20,788,527
- Total 13F shares
- 146,311,934
- Share change
- +19,395,172
- Total reported value
- $3,432,643,057
- Put/Call ratio
- 33%
- Price per share
- $23.47
- Number of holders
- 198
- Value change
- +$471,797,573
- Number of buys
- 102
- Number of sells
- 92
Quarterly Holders Quick Answers
What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - Nektar Therapeutics - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 640268108:
Top shareholders of NKTR - Nektar Therapeutics - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| OppenheimerFunds, Inc. |
13F
|
Company |
120%
|
25,008,320
|
$306,852,000 | — | 31 Dec 2016 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
103%
|
21,436,186
|
$263,022,000 | — | 31 Dec 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
67%
|
13,843,692
|
$169,862,000 | — | 31 Dec 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
62%
|
12,973,280
|
$159,182,000 | — | 31 Dec 2016 | |
| Camber Capital Management LP |
13F
|
Company |
29%
|
6,000,000
|
$73,620,000 | — | 31 Dec 2016 | |
| Invesco Ltd. |
13F
|
Company |
21%
|
4,438,815
|
$54,465,000 | — | 31 Dec 2016 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
20%
|
4,188,777
|
$51,396,000 | — | 31 Dec 2016 | |
| STATE STREET CORP |
13F
|
Company |
20%
|
4,062,468
|
$49,839,000 | — | 31 Dec 2016 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
19%
|
3,944,692
|
$48,401,000 | — | 31 Dec 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
18%
|
3,755,197
|
$46,076,000 | — | 31 Dec 2016 | |
| NORGES BANK |
13F
|
Company |
12%
|
2,573,278
|
$31,574,000 | — | 31 Dec 2016 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
10%
|
2,083,429
|
$25,564,000 | — | 31 Dec 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
9.4%
|
1,958,602
|
$24,032,000 | — | 31 Dec 2016 | |
| Granahan Investment Management, LLC |
13F
|
Company |
8.7%
|
1,816,305
|
$22,286,000 | — | 31 Dec 2016 | |
| JANUS HENDERSON INVESTORS US LLC |
13F
|
Company |
8.6%
|
1,788,352
|
$21,946,000 | — | 31 Dec 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
8.5%
|
1,766,465
|
$21,675,000 | — | 31 Dec 2016 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
7.2%
|
1,489,045
|
$18,271,000 | — | 31 Dec 2016 | |
| FMR LLC |
13F
|
Company |
6.6%
|
1,367,303
|
$16,777,000 | — | 31 Dec 2016 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
5.9%
|
1,218,700
|
$14,953,000 | — | 31 Dec 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.7%
|
1,188,735
|
$14,585,000 | — | 31 Dec 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
5.7%
|
1,183,582
|
$14,523,000 | — | 31 Dec 2016 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
5.2%
|
1,085,113
|
$13,314,000 | — | 31 Dec 2016 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
5.2%
|
1,078,454
|
$13,233,000 | — | 31 Dec 2016 | |
| MORGAN STANLEY |
13F
|
Company |
5.1%
|
1,058,967
|
$12,994,000 | — | 31 Dec 2016 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
4.9%
|
1,028,819
|
$12,624,000 | — | 31 Dec 2016 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
4.9%
|
1,024,300
|
$12,568,000 | — | 31 Dec 2016 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
4.9%
|
1,013,992
|
$12,442,000 | — | 31 Dec 2016 | |
| Artal Group S.A. |
13F
|
Company |
4.8%
|
1,000,000
|
$12,270,000 | — | 31 Dec 2016 | |
| MARSHALL WACE, LLP |
13F
|
Company |
4%
|
829,982
|
$10,184,000 | — | 31 Dec 2016 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
3.7%
|
767,542
|
$9,418,000 | — | 31 Dec 2016 | |
| SYSTEMATIC FINANCIAL MANAGEMENT LP |
13F
|
Company |
3.6%
|
745,229
|
$9,144,000 | — | 31 Dec 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
3.5%
|
733,599
|
$9,001,000 | — | 31 Dec 2016 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
2.9%
|
600,363
|
$7,366,000 | — | 31 Dec 2016 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
2.8%
|
576,813
|
$7,078,000 | — | 31 Dec 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
2.8%
|
572,247
|
$7,019,000 | — | 31 Dec 2016 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
2.6%
|
530,820
|
$6,513,000 | — | 31 Dec 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.3%
|
480,039
|
$5,890,000 | — | 31 Dec 2016 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
2.1%
|
427,098
|
$5,240,000 | — | 31 Dec 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2%
|
417,312
|
$5,120,000 | — | 31 Dec 2016 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
2%
|
410,000
|
$5,031,000 | — | 31 Dec 2016 | |
| HARVEY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.6%
|
342,700
|
$4,204,000 | — | 31 Dec 2016 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
1.6%
|
335,851
|
$4,121,000 | — | 31 Dec 2016 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
1.6%
|
325,456
|
$3,993,000 | — | 31 Dec 2016 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.6%
|
324,999
|
$3,988,000 | — | 31 Dec 2016 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.5%
|
312,841
|
$3,839,000 | — | 31 Dec 2016 | |
| BlackRock Group LTD |
13F
|
Company |
1.5%
|
303,242
|
$3,722,000 | — | 31 Dec 2016 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
1.4%
|
293,442
|
$3,601,000 | — | 31 Dec 2016 | |
| CITIGROUP INC |
13F
|
Company |
1.4%
|
282,367
|
$3,465,000 | — | 31 Dec 2016 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
1.3%
|
265,043
|
$3,252,000 | — | 31 Dec 2016 | |
| Legal & General Group Plc |
13F
|
Company |
1.3%
|
264,165
|
$3,241,000 | — | 31 Dec 2016 |
Institutional Holders of Nektar Therapeutics - Common Stock (NKTR) as of Q1 2017
As of 31 Mar 2017,
Nektar Therapeutics - Common Stock (NKTR) was held by
198 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
146,311,934 shares.
The largest 10 holders included
OppenheimerFunds, Inc., PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, Camber Capital Management LLC, Invesco Ltd., WESTFIELD CAPITAL MANAGEMENT CO LP, STATE STREET CORP, BRIDGER MANAGEMENT, LLC, and JPMORGAN CHASE & CO.
This page lists
198
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
196
Q1 2017 holders
198
Holder diff
2
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 Value $ | Q1 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.